These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2028777)

  • 1. Topical indomethacin for vernal keratoconjunctivitis.
    Gupta S; Khurana AK; Ahluwalia BK; Gupta NC
    Acta Ophthalmol (Copenh); 1991 Feb; 69(1):95-8. PubMed ID: 2028777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis.
    Sharma A; Gupta R; Ram J; Gupta A
    Indian J Ophthalmol; 1997 Sep; 45(3):177-80. PubMed ID: 9475021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cyclosporin A 2% eyedrops in therapy of atopic and vernal keratoconjunctivitis].
    Tomida I; Schlote T; Bräuning J; Heide PE; Zierhut M
    Ophthalmologe; 2002 Oct; 99(10):761-7. PubMed ID: 12376851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
    Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.
    Vichyanond P; Pacharn P; Pleyer U; Leonardi A
    Pediatr Allergy Immunol; 2014 Jun; 25(4):314-22. PubMed ID: 24438133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis.
    Mantelli F; Santos MS; Petitti T; Sgrulletta R; Cortes M; Lambiase A; Bonini S
    Br J Ophthalmol; 2007 Dec; 91(12):1656-61. PubMed ID: 17588996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical flurbiprofen therapy in vernal keratoconjunctivitis.
    Sud RN; Greval RS; Bajwa RS
    Indian J Med Sci; 1995 Sep; 49(9):205-9. PubMed ID: 8906937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical cyclosporine a 0.05% eyedrops in the treatment of vernal keratoconjunctivitis - randomized placebo-controlled trial.
    Keklikci U; Dursun B; Cingu AK
    Adv Clin Exp Med; 2014; 23(3):455-61. PubMed ID: 24979519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of vernal keratoconjunctivitis with topical cromolyn sodium.
    Chin GN
    J Pediatr Ophthalmol Strabismus; 1978; 15(5):326-9. PubMed ID: 24877437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of antiprostaglandin therapy in vernal conjunctivitis.
    Meyer E; Kraus E; Zonis S
    Br J Ophthalmol; 1987 Jul; 71(7):497-9. PubMed ID: 3115287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis.
    Pucci N; Novembre E; Cianferoni A; Lombardi E; Bernardini R; Caputo R; Campa L; Vierucci A
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):298-303. PubMed ID: 12269651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of lodoxamide in vernal keratoconjunctivitis.
    Das D; Khan M; Gul A; Alam R
    J Pak Med Assoc; 2011 Mar; 61(3):239-41. PubMed ID: 21465936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical bromfenac sodium for long-term management of vernal keratoconjunctivitis.
    Uchio E; Itoh Y; Kadonosono K
    Ophthalmologica; 2007; 221(3):153-8. PubMed ID: 17440276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical cyclosporin A in the management of vernal keratoconjunctivitis.
    Gupta V; Sahu PK
    Eye (Lond); 2001 Feb; 15(Pt 1):39-41. PubMed ID: 11318292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A prospective, observational, all-prescribed-patients study of cyclosporine 0.1% ophthalmic solution in the treatment of vernal keratoconjunctivitis].
    Takamura E; Uchio E; Ebihara N; Okamoto S; Kumagai N; Shoji J; Nakagawa Y; Namba K; Fukushima A; Fujishima H; Miyazaki D; Ohashi Y
    Nippon Ganka Gakkai Zasshi; 2011 Jun; 115(6):508-15. PubMed ID: 21735754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.
    Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E
    Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of prostaglandin E2 and leukotriene B4 in tears of vernal conjunctivitis patients during a therapeutic trial with indomethacin.
    Nathan H; Naveh N; Meyer E
    Doc Ophthalmol; 1994; 85(3):247-57. PubMed ID: 7924852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study.
    Pucci N; Caputo R; di Grande L; de Libero C; Mori F; Barni S; di Simone L; Calvani A; Rusconi F; Novembre E
    Pediatr Allergy Immunol; 2015 May; 26(3):256-261. PubMed ID: 25712437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-mobility group box-1 (HMGB-1) and serum soluble receptor for advanced glycation end products (sRAGE) in children affected by vernal keratoconjunctivitis.
    Zicari AM; Zicari A; Nebbioso M; Mari E; Celani C; Lollobrigida V; Cesoni Marcelli A; Occasi F; Duse M
    Pediatr Allergy Immunol; 2014 Feb; 25(1):57-63. PubMed ID: 24236762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of a new therapy using rebamipide eyedrops in patients with VKC/AKC refractory to conventional anti-allergic treatments.
    Ueta M; Sotozono C; Koga A; Yokoi N; Kinoshita S
    Allergol Int; 2014 Mar; 63(1):75-81. PubMed ID: 24457813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.